Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study Source: Eur Respir J 2003; 21: 1012-1016 Year: 2003
Risk factors for asymptomatic atrial fibrillation in patients with COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018
Predictors for high ventricular arrhythmia burden in patients with heart failure with reduced ejection fraction and central sleep apnea: an analysis of the SERVE-HF major substudy Source: Sleep and Breathing Conference 2021 Year: 2021
Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction ? A case-control study. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018
Assessment of atrial overdrive pacing as a treatment for OSAHS. (A prospective, randomized crossover study) Source: Eur Respir J 2005; 26: Suppl. 49, 564s Year: 2005
Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study Source: Eur Respir J, 57 (4) 2004055; 10.1183/13993003.04055-2020 Year: 2021
Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study. Source: International Congress 2019 – More and more COPD Year: 2019
Atrial fibrillation in critical care patients with respiratory failure: Incidence and clinical effects Source: Annual Congress 2012 - Multidisciplinary critical care Year: 2012
Predictors of lung function decline: a retrospective study in COPD patients Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018
Impaired pulmonary function and the risk of tuberculosis: a population-based cohort study Source: Eur Respir J 2011; 37: 1285-1287 Year: 2011
Evaluation of a new cardiac arrhythmias predictor in patients with COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018
Atrial arrhythmias after lung transplantation: prevalence, risk factors, management and outcome Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients Year: 2018
Assessment of atrial arrhythmogenic risk factors with body surface potential mapping in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 351s Year: 2005
COPD maintenance therapy is related to left heart size: Results from the multicenter long-term observation COSYCONET Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021
Prevalence and outcomes of pulmonary hypertension after percutaneous closure of atrial septal defect: a systematic review and meta-analysis Source: Eur Respir Rev, 29 (158) 200099; 10.1183/16000617.0099-2020 Year: 2020
The role of interleukin 6 on incident atrial fibrillation in COPD patients Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018
Long-term survival in pulmonary hypertension with atrial septostomy: a single center experience Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020
Non-aponea sleep disorder increases the risk of incident heart failure - a nationwide population-based cohort study Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018
D-dimer as a predictor of persistent pulmonary function impairment after COVID-19 pneumonia: a prospective observational study Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021
Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study Source: Eur Respir J, 50 (1) 1700094; 10.1183/13993003.00094-2017 Year: 2017